Is Charles River Laboratories International Inc (CRL) Overvalued After 5.1% Rally? GF Value Says Overvalued

gurufocus.com · 2026-10-20

On October 20, 2026, Charles River Laboratories International Inc (CRL) shares rose 5.1% to a current price of $315.45. The stock has seen a significant price i

TickrTrends take: Charles River Laboratories has experienced a recent price increase, yet TickrTrends' valuation analysis continues to indicate the stock trades above its intrinsic value estimate. The company's Healthcare sector position and the persistent overvaluation assessment suggest that investors focused on valuation metrics should monitor whether the stock's valuation gap narrows through either price adjustment or improved financial performance. A valuation-conscious investor would need to see fundamental improvements or multiple compression before the stock aligns with intrinsic value estimates.

Read the full story at gurufocus.com →